LIDOCAINE AND GLYCERIN

LIDOCAINE AND GLYCERIN was reported 22 times

LIDOCAINE AND GLYCERIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 THYROID ATROPHY 6 0.0638
1 PRECANCEROUS LESION OF DIGESTIVE TRACT 1 0.0088
2 BLOOD GASTRIN INCREASED 1 0.0078
3 CARCINOID TUMOUR OF THE STOMACH 1 0.0071
4 GENITAL LESION 1 0.0024
5 BLOOD CHROMOGRANIN A INCREASED 1 0.0022
6 ESSENTIAL HYPERTENSION 3 0.0016
7 PERNICIOUS ANAEMIA 1 0.0016
8 VITAMIN B12 DEFICIENCY 6 0.0015
9 ABSCESS NECK 1 0.0015
10 MALABSORPTION 6 0.0011
11 PROCTALGIA 7 0.0011
12 SMALL INTESTINAL RESECTION 1 0.0009
13 BILIARY TRACT DISORDER 1 0.0007
14 NEUROENDOCRINE TUMOUR 1 0.0007
15 GASTROINTESTINAL WALL THICKENING 1 0.0007
16 REGURGITATION 2 0.0006
17 MYOCLONUS 6 0.0005
18 HYPERLIPIDAEMIA 6 0.0005
19 ANORECTAL DISORDER 1 0.0005
20 CHRONIC GASTRITIS 1 0.0004
21 GASTROINTESTINAL MOTILITY DISORDER 2 0.0004
22 HAEMORRHOIDS 7 0.0004
23 FIBROMYALGIA 6 0.0002
24 TONGUE DISCOMFORT 1 0.0002
25 ANGINA PECTORIS 6 0.0002
26 SUBCUTANEOUS ABSCESS 1 0.0002
27 TRANSIENT ISCHAEMIC ATTACK 7 0.0002
28 HYPOTHYROIDISM 6 0.0002
29 LYMPHADENOPATHY 6 0.0002
30 RECTAL HAEMORRHAGE 7 0.0002
31 INFUSION SITE SWELLING 1 0.0002
32 WALKING AID USER 1 0.0002
33 OSTEOPOROSIS 6 0.0001
34 RESPIRATION ABNORMAL 1 0.0001
35 DROOLING 1 0.0001
36 LARGE INTESTINE POLYP 1 0.0001
37 HYPOKALAEMIA 6 0.0001
38 UTERINE CANCER 1 0.0001
39 ABNORMAL FAECES 1 0.0001
40 INFUSION SITE ERYTHEMA 1 0.0001
41 INCONTINENCE 1 0.0001
42 FISTULA 1 0.0001
43 METASTASES TO LUNG 1 0.0001
44 GASTROOESOPHAGEAL REFLUX DISEASE 6 0.0001
45 DYSPHAGIA 7 0.0001
46 ATRIAL FIBRILLATION 7 0.0001
47 HYPERTHYROIDISM 1 0.0001
48 LYMPHOMA 1 0.0001
49 EAR PAIN 1 0.0001
50 FAECES DISCOLOURED 1 0.0000
51 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
52 APPLICATION SITE PAIN 1 0.0000
53 GASTRIC CANCER 1 0.0000
54 RESPIRATORY TRACT INFECTION 1 0.0000
55 GASTRITIS 1 0.0000
56 FREQUENT BOWEL MOVEMENTS 1 0.0000
57 DIVERTICULITIS 1 0.0000
58 APHASIA 1 0.0000
59 SWOLLEN TONGUE 1 0.0000
60 HIP FRACTURE 1 0.0000
61 LIP SWELLING 1 0.0000
62 GAIT INABILITY 1 0.0000
63 INJECTION SITE MASS 1 0.0000
64 DYSKINESIA 1 0.0000
65 SKIN DISCOLOURATION 1 0.0000
66 PRODUCTIVE COUGH 1 0.0000
67 DRY EYE 1 0.0000
68 SINUSITIS 2 0.0000
69 FLATULENCE 1 0.0000
70 DYSPHONIA 1 0.0000
71 PALPITATIONS 2 0.0000
72 SURGERY 1 0.0000
73 ARTHRALGIA 7 0.0000
74 SWELLING FACE 1 0.0000
75 HYPERTENSION 3 0.0000
76 ACNE 1 0.0000
77 ARTHRITIS 1 0.0000
78 MYALGIA 2 0.0000
79 MUSCULOSKELETAL STIFFNESS 1 0.0000
80 TACHYCARDIA 1 0.0000
81 CHEST PAIN 2 0.0000
82 CARDIAC DISORDER 1 0.0000
83 DRUG INTOLERANCE 1 0.0000
84 FLUSHING 1 0.0000
85 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
86 ABDOMINAL DISTENSION 1 0.0000
87 MUSCULAR WEAKNESS 1 0.0000
88 DISEASE PROGRESSION 1 0.0000
89 LOSS OF CONSCIOUSNESS 1 0.0000
90 DIARRHOEA 5 0.0000
91 PSORIASIS 1 0.0000
92 DEHYDRATION 1 0.0000
93 MEMORY IMPAIRMENT 1 0.0000
94 BLOOD PRESSURE INCREASED 1 0.0000
95 VOMITING 3 0.0000
96 TREMOR 1 0.0000
97 URINARY TRACT INFECTION 1 0.0000
98 COVID-19 1 0.0000
99 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
100 NASOPHARYNGITIS 1 0.0000
101 HYPOTENSION 1 0.0000
102 BACK PAIN 1 0.0000
103 FEELING ABNORMAL 1 0.0000
104 WEIGHT DECREASED 1 0.0000
105 ANXIETY 1 0.0000
106 PAIN 2 0.0000
107 DRUG INEFFECTIVE 4 0.0000
108 PYREXIA 1 0.0000
109 ASTHENIA 1 0.0000
110 FATIGUE 2 0.0000
111 NAUSEA 2 0.0000
112 RASH 1 0.0000
113 DEATH 1 0.0000